Jonathan Schechter
Director · PharmaCyte Biotech, Inc.
IndividualBuying only
- 2025
- Jul 17, 2026
- 9
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jonathan Schechter files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Joshua Silverman - $80K in PMCB purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jonathan Schechter?
Jonathan Schechter is a corporate insider, tracked as Director of PharmaCyte Biotech, Inc. (PMCB). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jonathan Schechter submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Jonathan Schechter been buying or selling stock?
Recorded transactions: 6 open-market purchases ($108K) and 0 open-market sales across all tracked filings.
